Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061394) titled 'Comparative Longitudinal Evaluation of Autologous Dermal Fibroblasts and Adipose-Derived Stem Cells for Facial Skin Quality: An Exploratory Pilot Clinical Study' on April 27.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Chuo Beauty Clinic, Umeda Osaka Ekimae Clinic
Condition:
Condition - Skin aging in healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To retrospectively evaluate and compare longitudinal changes in facial skin quality following autologous dermal fibroblast and adipose-derived stem cell therapy using clinical data.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Healthy adults who underwent facial rejuvenation treatment
Availability of baseline clinical data
Key exclusion criteria - Severe skin disease
Deemed unsuitable by investigator
Target Size - 6
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2024 Year 07 Month 04 Day
Date of IRB - 2026 Year 04 Month 12 Day
Anticipated trial start date - 2024 Year 08 Month 01 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070243
Disclaimer: Curated by HT Syndication.
